SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-23-001518
Filing Date
2023-12-18
Accepted
2023-12-18 21:26:15
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3661
  Complete submission text file 0001593968-23-001518.txt   5261
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Li Yang (Reporting) CIK: 0001990537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 231495462